Medibank Private Limited (MPL.AX) vs The9 Limited (NCTY)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| MPL.AX | NCTY | |
|---|---|---|
| Sector | Financial Services | Financial Services |
| Industry | Insurance - Specialty | Capital Markets |
| Size band | MID | SMALL |
| Listing | ASX | Nasdaq CM |
| Country | Australia | China |
| Theme | health-insurance | bitcoin-mining |
| Price and returns | ||
| Last close | 5.05 AUD | $3.28 |
| Return · 1 week | +5.65% | 0.00% |
| Return · 1 month | +10.99% | −1.80% |
| Return · 3 months | −3.63% | −29.00% |
| Return · year to date | +6.99% | −47.35% |
| Return · 1 year | +7.44% | −67.81% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −4.90% | −68.88% |
| 52-week high | 5.31 AUD | $10.54 |
| 52-week low | 4.06 AUD | $3.09 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $9.76B | $50.10M |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $30.90M | $620.58K |
| Employees | 5,001 | 44 |
| Valuation | ||
| Price to earnings · trailing | 19.87× | n/a (negative earnings) |
| Price to earnings · forward | 17.02× | — |
| Price to sales | 1.35× | 0.75× |
| Price to book | 5.18× | 0.53× |
| Enterprise value to EBITDA | 9.52× | n/a (negative EBITDA) |
| Enterprise value to revenue | 1.00× | 3.53× |
| PEG ratio | — | n/a (negative value) |
| Earnings per share · trailing | 0.23 | -0.86 |
| Profitability | ||
| Gross margin | — | 12.27% |
| Operating margin | 10.72% | −1232.76% |
| Profit margin | 6.87% | 69.50% |
| Return on equity | 27.23% | 7.13% |
| Return on assets | 12.65% | −29.09% |
| Growth | ||
| Revenue growth | +12.60% | −80.80% |
| Earnings growth | +109.90% | — |
| Balance sheet and payout | ||
| Debt / equity (%) | 11.36 | 36.51 |
| Current ratio | 1.96 | 2.57 |
| Dividend yield | 4.22% | 0.00% |
| Payout ratio | 79.74% | 0.00% |
| Trend and volatility | ||
| RSI · 14 | 75.65 | 41.80 |
| ADX · 14 | 30.50 | 7.58 |
| 50-day average | 4.69 AUD | $3.92 |
| 200-day average | 4.71 AUD | $5.01 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 1.82% | 5.77% |
The full MPL.AX analysis
Everything this table leaves out for Medibank Private Limited: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the MPL.AX argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full MPL.AX analysisThe full NCTY analysis
Everything this table leaves out for The9 Limited: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the NCTY argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full NCTY analysis